CLBFX
Price
$40.43
Change
-$0.06 (-0.15%)
Updated
Jun 26 closing price
Net Assets
287.61B
ICMBX
Price
$14.77
Change
+$0.12 (+0.82%)
Updated
Jul 2 closing price
Net Assets
126.52M
Interact to see
Advertisement

CLBFX vs ICMBX

CLBFX vs ICMBX Comparison Chart in %
View a ticker or compare two or three
VS
CLBFX vs. ICMBX commentary
Jul 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBFX is a Buy and ICMBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBFX has more cash in the bank: 288B vs. ICMBX (127M). CLBFX pays higher dividends than ICMBX: CLBFX (1.92) vs ICMBX (1.64). CLBFX was incepted earlier than ICMBX: CLBFX (24 years) vs ICMBX (22 years). ICMBX (1.73) is less costly to investors than CLBFX (0.66). CLBFX is a more actively managed with annual turnover of: 50.00 vs. ICMBX (47.00). CLBFX has a lower initial minimum investment than ICMBX: CLBFX (250) vs ICMBX (2500). ICMBX annual gain was more profitable for investors over the last year : 14.19 vs. CLBFX (12.93). ICMBX return over 5 years is better than : 38.93 vs. CLBFX (36.42).
CLBFXICMBXCLBFX / ICMBX
Total Expense Ratio0.661.4147%
Annual Report Gross Expense Ratio0.661.7338%
Fund Existence24 years22 years-
Gain YTD8.9646.604136%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets288B127M226,772%
Annual Yield % from dividends1.921.64117%
Returns for 1 year12.9314.1991%
Returns for 3 years42.3149.5185%
Returns for 5 years36.4238.9394%
Returns for 10 years99.5569.41143%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGLCX12.600.21
+1.69%
Brookfield Global Listed InfrastructureC
RGEAX11.980.05
+0.42%
Russell Inv Global Equity A
TCEPX51.71N/A
N/A
Nuveen Equity Index Premier
AVEGX57.21-0.48
-0.83%
Ave Maria Growth
EMPTX12.91-0.14
-1.07%
UBS Emerging Markets Equity Opp P2